ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.71
-0.56%
US Tech 100
18,228.40
0.00%
S&P 500
5,307.01
-0.27%
US Dollar vs CAD
1.36812
-0.08%
Bitcoin
69,479.00
0.54%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. AMEX
  6. China Pharma Holdings Inc (CPHI)

  7. China Pharma Holdings Inc (CPHI) News

CPHI

China Pharma (CPHI)

China Pharma Holdings Inc
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:CPHI
DateTimeSourceHeadlineSymbolCompany
05/15/20243:06PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:CPHIChina Pharma Holdings Inc
05/08/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:CPHIChina Pharma Holdings Inc
02/23/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:CPHIChina Pharma Holdings Inc
02/23/20243:05PMPR Newswire (US)China Pharma Holdings Inc. Announces 1-for-5 Reverse Stock SplitAMEX:CPHIChina Pharma Holdings Inc
02/14/202411:15PMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessAMEX:CPHIChina Pharma Holdings Inc
02/08/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:CPHIChina Pharma Holdings Inc
02/06/20243:16PMEdgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]AMEX:CPHIChina Pharma Holdings Inc
01/26/20244:04PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsAMEX:CPHIChina Pharma Holdings Inc
01/26/20244:04PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesAMEX:CPHIChina Pharma Holdings Inc
01/12/20243:05PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933AMEX:CPHIChina Pharma Holdings Inc
01/12/20241:42PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]AMEX:CPHIChina Pharma Holdings Inc
12/21/20233:05PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:CPHIChina Pharma Holdings Inc
12/19/20233:05PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:CPHIChina Pharma Holdings Inc
11/29/20237:00AMPR Newswire (US)China Pharma Holdings, Inc. Announced the Completion of Third Party Testing of Dry Eye Disease Therapeutic DeviceAMEX:CPHIChina Pharma Holdings Inc
11/13/20233:05PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:CPHIChina Pharma Holdings Inc
11/07/20233:05PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsAMEX:CPHIChina Pharma Holdings Inc
10/27/20233:06PMEdgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsAMEX:CPHIChina Pharma Holdings Inc
10/19/20233:06PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:CPHIChina Pharma Holdings Inc
10/03/20233:05PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:CPHIChina Pharma Holdings Inc
08/14/20232:40PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:CPHIChina Pharma Holdings Inc
08/09/20237:30AMPR Newswire (US)China Pharma's Candesartan Hypertension Product Passes the Quality and Efficacy Consistency Evaluation of Generic DrugsAMEX:CPHIChina Pharma Holdings Inc
05/12/20233:07PMEdgar (US Regulatory)Quarterly Report (10-q)AMEX:CPHIChina Pharma Holdings Inc
03/30/20233:56PMEdgar (US Regulatory)Annual Report (10-k)AMEX:CPHIChina Pharma Holdings Inc
03/29/20233:06PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:CPHIChina Pharma Holdings Inc
03/09/20233:07PMEdgar (US Regulatory)Statement of Ownership (sc 13g)AMEX:CPHIChina Pharma Holdings Inc
03/09/20233:06PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:CPHIChina Pharma Holdings Inc
02/24/20233:07PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:CPHIChina Pharma Holdings Inc
02/24/20233:05PMPR Newswire (US)China Pharma Holdings Inc. Announces 1-for-10 Reverse Stock SplitAMEX:CPHIChina Pharma Holdings Inc
12/30/20223:06PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:CPHIChina Pharma Holdings Inc
12/28/20227:00AMPR Newswire (US)China Pharma Holdings, Inc. Announced the Launch of N95 Medical Protective MaskAMEX:CPHIChina Pharma Holdings Inc
 Showing the most relevant articles for your search:AMEX:CPHI

Your Recent History

NASDAQ
NVDA
NVIDIA
USOTC
RDGL
Vivos (QB)
USOTC
ENZC
Enzolytics (PK)
USOTC
CBIA
Canopus Biopharma (PK)
USOTC
UBQU
Ubiquitech Software (PK)
USOTC
DPLS
DarkPulse (PK)
AMEX
SPY
SPDR S&P 500
USOTC
VPLM
Voip Pal Com (QB)
NASDAQ
RVNC
Revance Therapeutics
USOTC
SONGD
Music Licensing (PK)
USOTC
GNCP
GNCC Capital (CE)
USOTC
BLEG
Branded Legacy (PK)
USOTC
AXXA
Exxe (PK)
NASDAQ
FCEL
FuelCell Energy
NASDAQ
LWLG
Lightwave Logic
NASDAQ
AVXL
Anavex Life Sciences
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved